CompletedPhase 3NCT01124838

Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis

Studying Infectious panuveitis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: AbbVie (prior sponsor, Abbott)
Principal Investigator: Andy Payne
AbbVie
Intervention: Adalimumab(drug)
Enrollment: 261 enrolled
Eligibility: 18-99 years · All sexes
Timeline: 2010 – 2015

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01124838 on ClinicalTrials.gov

← Back to all trials